BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye BD, Yang SK, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim YH, Lee H. [Guidelines for the management of Crohn’s disease]. Korean J Gastroenterol. 2012;59:141-179. [PMID: 22387837 DOI: 10.4166/kjg.2012.59.2.141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Lee JY, Oh K, Hong HS, Kim K, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Lee HS, Jo KW, Park SH. Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea. BMC Gastroenterol 2021;21:390. [PMID: 34670529 DOI: 10.1186/s12876-021-01973-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ha JE, Jang EJ, Im SG, Sohn HS. Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014). Korean J Clin Pharm 2019;29:79-88. [DOI: 10.24304/kjcp.2019.29.2.79] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Choi YJ, Choi EK, Han KD, Park J, Moon I, Lee E, Choe WS, Lee SR, Cha MJ, Lim WH, Oh S. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2019; 25(22): 2788-2798 [PMID: 31236001 DOI: 10.3748/wjg.v25.i22.2788] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
4 Kim ES, Kim KO, Jang BI, Lee CK, Kim HJ, Lee KM, Kim YS, Eun CS, Jung SA, Yang SK, Lee J, Kim TO, Jung Y, Seo GS, Yoon SM; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases (KASID). Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study). Gut Liver 2016;10:391-8. [PMID: 26347512 DOI: 10.5009/gnl15126] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
5 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. [Second Korean Guidelines for the Management of Crohn's Disease]. Korean J Gastroenterol 2017;69:29-54. [PMID: 28135790 DOI: 10.4166/kjg.2017.69.1.29] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of Crohn's disease. Intest Res 2017;15:38-67. [PMID: 28239314 DOI: 10.5217/ir.2017.15.1.38] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
7 Yoshida A, Ueno F, Morizane T, Joh T, Kamiya T, Takahashi S, Tokunaga K, Iwakiri R, Kinoshita Y, Suzuki H, Naito Y, Uchiyama K, Fukodo S, Chan FK, Halm K, Kachintorn U, Fock KM, Rani AA, Syam AF, Sollano JD, Zhu Q, The International Gastroenterology Consensus Symposium Study Group. Asian Perspectives on Diagnostic and Therapeutic Strategies in Inflammatory Bowel Disease: Report and Analysis of a Survey with Questionnaires. Digestion 2017;95:79-88. [DOI: 10.1159/000453007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Song DJ, Whang IS, Choi HW, Jeong CY, Jung SH. Crohn's disease confined to the duodenum: A case report. World J Clin Cases 2016; 4(6): 146-150 [PMID: 27326400 DOI: 10.12998/wjcc.v4.i6.146] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
9 Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
10 Cho YH, Chae MK, Cha JM, Lee JI, Joo KR, Shin HP, Baek IH, Jeon JW, Lim JU, Hong IT, Ki HJ, Kang JB. Cerebral venous thrombosis in a patient with Crohn's disease. Intest Res 2016;14:96-101. [PMID: 26884741 DOI: 10.5217/ir.2016.14.1.96] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
11 Choi JR, Yun GW, Park YM, Kim JH, Youn YH, Park HJ, Park JJ. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy]. Korean J Gastroenterol 2015;66:231-6. [PMID: 26493510 DOI: 10.4166/kjg.2015.66.4.231] [Reference Citation Analysis]
12 Kim I, Min KH, Yeo M, Kim JS, Lee SH, Lee SS, Shin KS, Youn SJ, Shin DI. Unusual Case of Cerebral Venous Thrombosis in Patient with Crohn's Disease. Case Rep Neurol 2015;7:115-20. [PMID: 26078745 DOI: 10.1159/000430805] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, Kim EY, Jeon SW, Lee HS, Yang CH, Lee YK, Lee DW, Kim SK, Kim TO, Lee J, Kim HW, Jee SR, Park SJ, Kim HJ. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol 2015; 21(11): 3308-3316 [PMID: 25805938 DOI: 10.3748/wjg.v21.i11.3308] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
14 Kim SB, Park SJ, Chung SH, Hahn KY, Moon DC, Hong SP, Cheon JH, Kim TI, Kim WH. Vaccination and complementary and alternative medicine in patients with inflammatory bowel disease. Intest Res 2014;12:124-30. [PMID: 25349579 DOI: 10.5217/ir.2014.12.2.124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
15 Park JJ. Appropriate Administration Timing and Clinical Indications of Thiopurine in Crohn's Disease. Korean J Gastroenterol 2014;63:194. [DOI: 10.4166/kjg.2014.63.3.194] [Reference Citation Analysis]
16 Ahn SM, Suh SO, Oh YM, Yun CY, Sim HH, Park CA, Song CM, Bae JY. [A case of pleomorphic liposarcoma in a patient with Crohn's disease taking azathioprine]. Korean J Gastroenterol 2013;62:248-52. [PMID: 24162714 DOI: 10.4166/kjg.2013.62.4.248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Kim E, Kang Y, Lee MJ, Park YN, Koh H. Life-threatening lower gastrointestinal hemorrhage in pediatric Crohn's disease. Pediatr Gastroenterol Hepatol Nutr. 2013;16:53-60. [PMID: 24010107 DOI: 10.5223/pghn.2013.16.1.53] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Park MS, Kim WJ, Huh JH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Crohn's duodeno-colonic fistula preoperatively closed using a detachable endoloop and hemoclips: a case report. Korean J Gastroenterol 2013;61:97-102. [PMID: 23458988 DOI: 10.4166/kjg.2013.61.2.97] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]